{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:33:51Z","timestamp":1763562831928,"version":"3.45.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-025-03949-3","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T07:21:40Z","timestamp":1750663300000},"page":"4500-4507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical impact following the establishment of a specialized brain metastases tumor board"],"prefix":"10.1007","volume":"27","author":[{"given":"Izaskun","family":"Valduvieco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Antelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3253-3448","authenticated-orcid":false,"given":"Alberto","family":"Di Somma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireia","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Capurro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MLourdes","family":"Olondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Arance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Ferrer-Mileo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iban","family":"Aldecoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carme","family":"Ares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanny","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Mosteiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquim","family":"Ense\u00f1at","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6215-2251","authenticated-orcid":false,"given":"Meritxell","family":"Moll\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"3949_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/EDBK_352320","volume":"42","author":"C Alvarez-Breckenridge","year":"2022","unstructured":"Alvarez-Breckenridge C, Remon J, Pi\u00f1a Y, Nieblas-Bedolla E, Forsyth P, et al. Emerging systemic treatment perspectives on brain metastases: moving toward a better outlook for patients. Am Soc Clin Oncol Educ Book. 2022;42:1\u201319. https:\/\/doi.org\/10.1200\/EDBK_352320.","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"12","key":"3949_CR2","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1016\/j.jtho.2023.06.017","volume":"18","author":"CS Gillespie","year":"2023","unstructured":"Gillespie CS, Mustafa MA, Richardson GE, Alam AM, Lee KS, Hughes DD, et al. Genomic alterations and the incidence of brain metastases in advanced and metastatic NSCLC: A systematic review and meta-analysis. J Thorac Oncol. 2023;18(12):1703\u201313. https:\/\/doi.org\/10.1016\/j.jtho.2023.06.017.","journal-title":"J Thorac Oncol"},{"issue":"10","key":"3949_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fonc.2020.00085","volume":"20","author":"M Taberna","year":"2020","unstructured":"Taberna M, Gil Moncayo F, Jan\u00e9-Salas E, Antonio M, Arribas L, Vilajosana E, et al. The multidisciplinary team (MDT) approach and quality of care. Front Oncol. 2020;20(10):85. https:\/\/doi.org\/10.3389\/fonc.2020.00085.","journal-title":"Front Oncol"},{"issue":"12","key":"3949_CR4","doi-asserted-by":"publisher","first-page":"1054490","DOI":"10.3389\/fonc.2022.1054490","volume":"19","author":"PE Fecci","year":"2022","unstructured":"Fecci PE, Rao G, Brastianos PK, Dunn GP, Anders CK. Editorial: It takes a village: The expanding multi-disciplinary approach to brain metastasis. Front Oncol. 2022;19(12):1054490. https:\/\/doi.org\/10.3389\/fonc.2022.1054490.","journal-title":"Front Oncol"},{"issue":"7","key":"3949_CR5","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/cncr.32714","volume":"126","author":"MJ Moravan","year":"2020","unstructured":"Moravan MJ, Fecci PE, Anders CK, Clarke JM, Salama AKS, Adamson JD, et al. Current multidisciplinary management of brain metastases. Cancer. 2020;126(7):1390\u2013406. https:\/\/doi.org\/10.1002\/cncr.32714.","journal-title":"Cancer"},{"issue":"5","key":"3949_CR6","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1200\/JCO.21.02314","volume":"40","author":"MA Vogelbaum","year":"2022","unstructured":"Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, et al. Treatment for brain metastases: ASCO-SNO-ASTRO guideline. J Clin Oncol. 2022;40(5):492\u2013516. https:\/\/doi.org\/10.1200\/JCO.21.02314.","journal-title":"J Clin Oncol"},{"issue":"11","key":"3949_CR7","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","volume":"32","author":"E Le Rhun","year":"2021","unstructured":"Le Rhun E, Guckenberger M, Smits M, Dummer R, Bachelot T, Sahm F, EANO Executive Board and ESMO Guidelines Committee, et al. EANO-ESMO clinical practice guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours. Ann Oncol. 2021;32(11):1332\u201347. https:\/\/doi.org\/10.1016\/j.annonc.2021.07.016.","journal-title":"Ann Oncol"},{"issue":"4","key":"3949_CR8","doi-asserted-by":"publisher","first-page":"352","DOI":"10.6004\/jnccn.2011.0036","volume":"9","author":"SS Brem","year":"2011","unstructured":"Brem SS, Bierman PJ, Brem H, Butowski N, Chamberlain MC, Chiocca EA, et al. National comprehensive cancer network. Central nervous system cancers. J Natl Compr Canc Netw. 2011;9(4):352\u2013400. https:\/\/doi.org\/10.6004\/jnccn.2011.0036.","journal-title":"J Natl Compr Canc Netw"},{"issue":"11","key":"3949_CR9","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.6004\/jnccn.2020.0052","volume":"18","author":"LB Nabors","year":"2020","unstructured":"Nabors LB, Portnow J, Ahluwalia M, Baehring J, Brem H, Brem S, et al. Central nervous system cancers, version 3.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2020;18(11):1537\u201370. https:\/\/doi.org\/10.6004\/jnccn.2020.0052.","journal-title":"J Natl Compr Canc Netw"},{"key":"3949_CR10","doi-asserted-by":"publisher","DOI":"10.21037\/tbcr-22-30","author":"T Wang","year":"2022","unstructured":"Wang T, Chen J, Yang J, Fu M, Hua W, Jia W, CSCO expert panel of breast cancer*; CSCO expert panel of breast cancer, et al. CSCO expert consensus on the diagnosis and treatment of breast cancer brain metastasis. Transl Breast Cancer Res. 2022. https:\/\/doi.org\/10.21037\/tbcr-22-30.","journal-title":"Transl Breast Cancer Res"},{"key":"3949_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2020.11.021","author":"Y Li","year":"2021","unstructured":"Li Y, Li Q, Mo H, Guan X, Lin S, Wang Z, et al. Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in China. The Breast. 2021. https:\/\/doi.org\/10.1016\/j.breast.2020.11.021.","journal-title":"Breast"},{"issue":"4","key":"3949_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.prro.2022.02.003","volume":"12","author":"V Gondi","year":"2022","unstructured":"Gondi V, Bauman G, Bradfield L, Burri SH, Cabrera AR, Cunningham DA, et al. Radiation therapy for brain metastases: an ASTRO clinical practice guideline. Pract Radiat Oncol. 2022;12(4):265\u201382. https:\/\/doi.org\/10.1016\/j.prro.2022.02.003.","journal-title":"Pract Radiat Oncol"},{"issue":"6","key":"3949_CR13","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1055\/s-0043-1776782","volume":"43","author":"S Bellur","year":"2023","unstructured":"Bellur S, Khosla AA, Ozair A, Kotecha R, McDermott MW, Ahluwalia MS. Management of brain metastases: A review of novel therapies. Semin Neurol. 2023;43(6):845\u201358. https:\/\/doi.org\/10.1055\/s-0043-1776782.","journal-title":"Semin Neurol"},{"issue":"14","key":"3949_CR14","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3332\/ecancer.2020.1136","volume":"5","author":"A Rajpurohit","year":"2020","unstructured":"Rajpurohit A, Purandare N, Moiyadi A, Shetty P, Mahajan A, Kumar R, et al. Multidisciplinary brain metastasis clinic: is it effective and worthwhile? Ecancermedicalscience. 2020;5(14):1136. https:\/\/doi.org\/10.3332\/ecancer.2020.1136.","journal-title":"Ecancermedicalscience"},{"issue":"10","key":"3949_CR15","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1093\/neuonc\/noac118","volume":"24","author":"AA Aizer","year":"2022","unstructured":"Aizer AA, Lamba N, Ahluwalia MS, Aldape K, Boire A, Brasitanos PK, et al. Brain metastases: a society for neuro-oncology (SNO) consensus review on current management and future directions. Neuro Oncol. 2022;24(10):1613\u201346. https:\/\/doi.org\/10.1093\/neuonc\/noac118.","journal-title":"Neuro Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-03949-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-025-03949-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-03949-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:28:54Z","timestamp":1763562534000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-025-03949-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":15,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3949"],"URL":"https:\/\/doi.org\/10.1007\/s12094-025-03949-3","relation":{},"ISSN":["1699-3055"],"issn-type":[{"type":"electronic","value":"1699-3055"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No conflicts of interest declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The protocol was approved by the HCB ethical committees and was carried out in accordance with the Declaration of\nHelsinki, the International Conference on Harmonization Guidelines for Good Clinical Practice, European Directive\n2001\/20\/EC, and ethical and legal requirements.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent For this type of study, no informed consent is reqired.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}